News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
SR Pharma PLC Gets Encouraging Results In Mice For Pancreatic Cancer Drug
September 14, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON (AFX) - SR Pharma plc said it and its operating subsidiary Atugen AG have received encouraging results in mice under studies on the therapeutic efficacy of Atu027 RNAi treating pancreatic cancer.
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
Europe
MORE ON THIS TOPIC
Funding
Degron adds $40M to series A, supporting immunology plans for molecular glue platform
May 14, 2026
·
2 min read
·
Tristan Manalac
Insights
From MSCs to iPSCs: building the cell therapy future
May 14, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Manufacturing
Bora inks $122.5M takeover of MacroGenics facility to further US expansion
May 13, 2026
·
2 min read
·
Nick Paul Taylor
Obesity
Lilly maintains weight loss leadership as Foundayo, Zepbound keep pounds off after switching
May 13, 2026
·
2 min read
·
Tristan Manalac
